Showing 7 posts of 7 posts found.


NHS England to fund Hemlibra for patients with severe haemophilia

August 21, 2019
Research and Development Chugai, Hemlibra, Roche, haemophilia, pharma

NHS England is to fund Roche and Chugai Pharma UK’s haemophilia drug Hemlibra, for people with sever congenital haemophilia A …


Roche and Chugai’s Hemlibra scoops up EU approval in the prevention of severe haemophilia A without factor VIII inhibitors

March 14, 2019
Sales and Marketing Chugai, Hemlibra, Roche, haemophilia, pharma

Roche has announced along with its partner Chugai that Hemlibra (emicizumab) has secured approval from the European Commission as a …


EMA committee recommends seven therapies from Roche, GSK, MSD and more

January 29, 2018
Sales and Marketing Biocon, Chiesi, Chugai, GSK, GlaxoSmithKline, MSD, Mylan, Roche, Sanofi, pharma

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has voiced its recommendation of a raft of …


Chugai partners with Osaka University in £62 million immunology collaboration

May 20, 2016
Medical Communications, Research and Development Chugai, collaboration, immunology, osaka university

Chugai Pharmaceuticals (TOKYO: 4519) has announced a collaboration agreement with Osaka University in advanced immunology research worth up to £62 …


Baxalta sues Chugai for haemophilia drug patent breach

May 11, 2016
Research and Development Baxalta, Chugai, breach, court, haemophilia, infringe, infringement, patent, sue, suing

Baxalta has taken Chugai Pharmaceuticals to the Tokyo district court, claiming that the Japanese company has infringed upon its patent …


Chugai falls foul of ABPI code for close consultant relationship

July 17, 2015
Medical Communications, Sales and Marketing ABPI Code, Chugai, PMCPA, Prescription Medicines Code of Practice Authority

Bosses at Chugai have been rapped by the industry’s code of practice regulator, after a senior manager failed to declare …

Twitter logo

Watchdog frowns on Botox tweet

February 15, 2012
Medical Communications Allergan, Chugai, PMCPA, Twitter

Allergan have been found in breach of the UK Code of Practice after an employee used Twitter to communicate about …

Latest content